The “reform” law made a number of dramatic changes to the private health insurance market, changing many standard practices and creating vast new markets through the public exchanges. Concerns have been raised on the effect of these changes on the prices paid by individuals who are now mandated to have coverage and on employer costs for health benefits. A report from the Rand organization looks at what the likely effect of all the changes will be on enrollment and premiums. (Rand Report) The authors used Rand’s long-standing insurance market model to try to understand these effects in ten geographically and demographically variable states. The model suggests that about 8.2% of people will still be uninsured in 2016, assuming full Medicaid expansion, versus 19.6% if the law were not in effect. In Minnesota the rate is projected to be only 5% and in Texas, 12%. Without that Medicaid expansion, the rate of the uninsured would be several points higher. The model also suggests that individual insurance enrollment will rise dramatically. The effect on rates is projected to be more uneven, with no change in five of the ten states, increases up to 43% in three and decreases in two. Similarly, small group enrollment is projected to rise while rates are relatively unaffected. If the filings to date in various states are examined, however, the number and size of premium increases appears to much greater than Rand’s model suggests. Rand and others tend to minimize the effect of premium changes by noting that many individuals will get subsidies. This is very misleading; those subsidies are paid for by the public in the form of direct taxes, or indirect ones in the form of higher costs for all goods and services, or foregone wages. The truth, which most proponents of the law do their best to try to ignore, is that the reform law is dramatically raising the cost of both health care and health care coverage for almost every citizen in the country.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Variation in Health Spending
February 16, 2025
Variation in Health Spending
Another interesting analysis of geographic variation in health spending.
Commentary
All Quiet on the Western Front
February 15, 2025
All Quiet on the Western Front
The pre-eminent description of war's impact on those who must fight it was written after…
Commentary
Yesterday’s 30-year US Bond Auction Did Not Go Well
February 14, 2025
Yesterday’s 30-year US Bond Auction Did Not Go Well
Warning signs aplenty if Congress does not get its act together on deficit reduction.